A Phase I Study of Mosunetuzumab for Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia
Clinical trial NCT05961696 · WITHDRAWN
Trial details
- NCT number
- NCT05961696
- Sponsor
- M.D. Anderson Cancer Center
- Status
- WITHDRAWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-07-05
- Primary completion
- 2023-10-03
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.